Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
Saved in:
| Title: | Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients. |
|---|---|
| Authors: | Li, Lu1 (AUTHOR), Chen, Lu2 (AUTHOR), Yan, Lu2 (AUTHOR), Guo, Yueqian3 (AUTHOR), Li, Fang1 (AUTHOR), Fan, Ming1 (AUTHOR), Lan, Mei1 (AUTHOR), Lai, Xin1 (AUTHOR), Zhou, Jie1 (AUTHOR), Huang, Yecai1 (AUTHOR), Xu, Peng1 (AUTHOR), Lang, Jinyi1 (AUTHOR), Feng, Mei1,4 (AUTHOR) freda_fm@126.com |
| Source: | Radiation Oncology. 7/4/2023, Vol. 18 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
